Literature DB >> 34355271

Parotid pleomorphic and non-pleomorphic adenomas: a mono-institutional series of 512 patients.

Davide Lombardi1, Michele Tomasoni2,3, Alessio Nicolai2, Alberto Paderno2,3, Alberto Grammatica2, Mara Arcuri2,3, Davide Lancini2, Simonetta Battocchio4, Laura Ardighieri4, Anna Bozzola4, Frida Pittiani5, Davide Farina5, Luca Oscar Redaelli de Zinis6, Piero Nicolai7, Cesare Piazza2,3.   

Abstract

PURPOSE: Pleomorphic adenoma (PA) is the most common benign parotid tumor, with a well-known propensity to recur. Many factors have been advocated as prognostic, but there is no consensus on how they affect local control. We studied how PA recurrence-free survival (RFS) may be affected by the most relevant risk factors in a time-to-event analysis, comparing them with those observed in a population of non-PA (NPA).
METHODS: Patients undergoing parotidectomy for benign lesions between 2002 and 2018 in a single academic tertiary referral center were included. A description of patients, tumors, and treatment characteristics was performed, highlighting differences between PA and NPA. Analysis of PA RFS and relative risk factors was also conducted.
RESULTS: Eight hundred fifty patients underwent parotidectomy for benign lesions, 455 (53.5%) for PA and 57 (6.7%) for NPA. Significant differences between PA and NPA were age at surgery, surgical procedure, and resection margins. Recurrence occurred in 3.1% of PA, with a median disease-free interval of 54 months. 2-, 5-, and 10-year RFS were 99.2, 98.5, and 93.9%, respectively. Age < 18 years (HR = 31.31, p < 0.001), intraoperative tumor spillage (HR = 6.57, p = 0.041), extensive pseudo-capsule interruption (HR = 5.85, p = 0.023), and resection margins < 1 mm (HR = 3.16, p = 0.085) were associated with RFS.
CONCLUSION: Patients affected by NPA were significantly older and treated with more conservative surgical procedures compared to those with PA. In PA, younger age, major pseudo-capsule defects, and surgical margins were the most relevant factors affecting local control. These results confirm the importance of an appropriate surgical management and long-term follow-up in PA.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Age; Parotid adenoma; Pleomorphic adenoma; Pseudo-capsule; Recurrent pleomorphic adenoma; Surgical margins

Mesh:

Year:  2021        PMID: 34355271     DOI: 10.1007/s00405-021-07018-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  26 in total

1.  Classification of parotidectomies: a proposal of the European Salivary Gland Society.

Authors:  M Quer; O Guntinas-Lichius; F Marchal; V Vander Poorten; D Chevalier; X León; D Eisele; P Dulguerov
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-10       Impact factor: 2.503

2.  Histopathology of pleomorphic adenoma in the parotid gland: a prospective unselected series of 100 cases.

Authors:  E Stennert; O Guntinas-Lichius; J P Klussmann; G Arnold
Journal:  Laryngoscope       Date:  2001-12       Impact factor: 3.325

3.  Evolution and changing trends in surgery for benign parotid tumors.

Authors:  Konstantinos Mantsopoulos; Michael Koch; Nils Klintworth; Johannes Zenk; Heinrich Iro
Journal:  Laryngoscope       Date:  2014-07-14       Impact factor: 3.325

Review 4.  Review of surgical techniques and guide for decision making in the treatment of benign parotid tumors.

Authors:  Georgios Psychogios; Christopher Bohr; Jannis Constantinidis; Martin Canis; Vincent Vander Poorten; Jan Plzak; Andreas Knopf; Christian Betz; Orlando Guntinas-Lichius; Johannes Zenk
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-04       Impact factor: 2.503

5.  [A pathological classification of pleomorphic adenoma of the salivary glands (author's transl)].

Authors:  G Seifert; I Langrock; K Donath
Journal:  HNO       Date:  1976-12       Impact factor: 1.284

6.  The range and demographics of salivary gland tumours diagnosed in a UK population.

Authors:  A V Jones; G T Craig; P M Speight; C D Franklin
Journal:  Oral Oncol       Date:  2007-09-06       Impact factor: 5.337

7.  The incidence of Warthin tumours and pleomorphic adenomas in the parotid gland over a 25-year period.

Authors:  J C Luers; O Guntinas-Lichius; J P Klussmann; C Küsgen; D Beutner; M Grosheva
Journal:  Clin Otolaryngol       Date:  2016-07-18       Impact factor: 2.597

8.  The management of salivary neoplasms: an overview.

Authors:  R H Spiro
Journal:  Auris Nasus Larynx       Date:  1985       Impact factor: 1.863

9.  Marginally excised parotid pleomorphic salivary adenomas: risk factors for recurrence and management. A 12.5-year mean follow-up study of histologically marginal excisions.

Authors:  S Ghosh; A Panarese; P D Bull; J A Lee
Journal:  Clin Otolaryngol Allied Sci       Date:  2003-06

10.  Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise.

Authors:  M McGurk; B L Thomas; A G Renehan
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.